Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Placebo-Controlled, Randomized Trial of Efficacy and Safety of Remaxol®, a Solution for Intravenous Infusions Produced by STPF "POLYSAN" (Russia), in Patients With Mechanical Jaundice of Non-Malignant Origin

NCT03418935 is registered in ClinicalTrials.gov with POLYSAN Scientific & Technological Pharmaceutical Company as lead sponsor.

NCT NCT03418935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03418935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Trial of Efficacy and Safety of Remaxol®, a Solution for Intravenous Infusions Produced by STPF "POLYSAN" (Russia), in Patients With Mechanical Jaundice of Non-Malignant Origin
Lead sponsor
POLYSAN Scientific & Technological Pharmaceutical Company
Phase
Phase 3
Overall status
Completed
Start date
April 3, 2017
Completion date
April 13, 2020
Enrollment
342 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

jaundice, obstructive